Get started
Author

Katherine Wolfrum

Risk Factors for CKD Progression
2020 · Mary Hannan, Sajid Ansari, et al. · Clinical Journal of the American Society of Nephrology · 164
Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest
2022 · John Mann, Mohammadreza Samieegohar, et al. · Clinical Pharmacology & Therapeutics · 54
PDF
Drug Interactions with the Dopamine Transporter in Cryopreserved Human Caudate
2001 · Amy J. Eshleman, Katherine Wolfrum, et al. · Journal of Pharmacology and Experimental Therapeutics · 20
Melittin initiates dopamine transporter internalization and recycling in transfected HEK-293 cells
2012 · Dove J. Keith, Katherine Wolfrum, et al. · European Journal of Pharmacology · 7
Deoxycholic Acid and Cognitive Impairment and Decline in the Chronic Renal Insufficiency Cohort (CRIC)
2025 · Parisa Mortaji, Xuan Cai, et al. · Kidney Medicine · 3
Characterization of CKD illness representation profiles using patient-level factors
2024 · Eleanor Rivera, Nathan Tintle, et al. · Journal of Nephrology · 1
Deoxycholic Acid (DCA) and Cognitive Impairment and Decline in the Chronic Renal Insufficiency Cohort (CRIC) Study
2021 · Kristen L. Nowak, Makoto Miyazaki, et al. · Journal of the American Society of Nephrology · 1
Formylated polyamines as peptidomimetics
2012 · Sacha Javor, Aaron Janowsky, et al. · Bioorganic & Medicinal Chemistry Letters · 1
Pharmacology of Newer Synthetic Cannabinoids at the CB1 Receptor
2025 · Laura Kozell, Amy Eshleman, et al. · Drug and Alcohol Dependence
Works count: 9
Citation count: 251
H-index: 4
I10-index: 3
Year
Topic
Type